CervoMed Inc (CRVO) SEC News Jan. 08, 2026, 21:08 UTC (99% Neutral) CervoMed Inc. (CRVO) Announces Regulatory Update Full text
Register to leave comments News bot Jan. 8, 2026, 9:11 p.m. 📋 CervoMed Inc. (CRVO) - Regulatory Update Filing Date: 2026-01-08 Accepted: 2026-01-08 16:08:44 Event Type: Regulatory Update Event Details: CervoMed Inc (CRVO) Announces Regulatory Update CervoMed Inc (CRVO) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 🔬 Clinical Development Pipeline (CervoMed Inc.): Product Type Development Stage Therapeutic Area Source Placebo DRUG Phase PHASE2 Dementia With Lewy Bodies ClinicalTrials.gov Neflamapimod DRUG Phase PHASE2 Dementia With Lewy Bodies ClinicalTrials.gov 💼 Business Developments: No business developments data available. Structured Data: Company Name: CervoMed IncCIK: 0001053691Ticker Symbol: CRVOPeriod End Date: 2026-01-07Document Type: 8-K
📋 CervoMed Inc. (CRVO) - Regulatory Update
Filing Date: 2026-01-08
Accepted: 2026-01-08 16:08:44
Event Type: Regulatory Update
Event Details:
🔬 Clinical Development Pipeline (CervoMed Inc.):
💼 Business Developments:
No business developments data available.
Structured Data: